Brief Internet Based Treatment for PTSD
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01760213|
Recruitment Status : Unknown
Verified December 2012 by Hadassah Medical Organization.
Recruitment status was: Not yet recruiting
First Posted : January 4, 2013
Last Update Posted : May 23, 2013
The goal of the project is to overcome some of the common barriers to treatment amongst recent survivors of traumatic events, by combining the world of evidence-based intervention with that of modern Internet technology. Specifically, it aims to test the feasibility and effectiveness of an Internet delivery of early-intervention trauma-focused cognitive behavioral therapy (CBT) for preventing post-traumatic stress disorder (PTSD). Over the course of the study the following objectives will be achieved:
- The development of an Internet-based Virtual Reality intervention for preventing PTSD among patients who have recently experienced a traumatic event.
- The evaluation of the feasibility of administering this intervention, and
- The evaluation of the efficacy of this Internet based intervention in the prevention of PTSD in recent trauma survivors.
|Condition or disease||Intervention/treatment||Phase|
|PTSD||Other: CBT delivered via Internet||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||900 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Internet Based Treatment Using Virtual Reality in the Prevention of PTSD|
|Study Start Date :||January 2013|
|Estimated Primary Completion Date :||January 2015|
|Estimated Study Completion Date :||August 2015|
intervention delivered via internet
Other: CBT delivered via Internet
|No Intervention: Control|
- Levels of PTSD symptoms [ Time Frame: 12 months after end of treatment ]the main outcome measure will be PTSD symptoms as measured by the CAPS.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01760213
|Contact: Rena Cooper, MDfirstname.lastname@example.org|
|Contact: Sara Freedman, PhDemail@example.com|
|Hadassah medical organization|
|Jerusalem, Israel, 91200|
|Principal Investigator:||Rena Cooper, MD||HMO|
|Study Director:||Sara Freedman, PhD||Bar Ilan University|